JRoon, my apologies right off the bat if I don't understand or explain all this correctly. Sarissa's goal is to turn this into a full fledged royalty company right? I believe your opinion is that in no way are they going to spend any cash on an acquisition, be it a company or a drug. So you would think that a hedge fund (or whatever they are) like Sarissa would not just park all that cash for those measly interest rates. Once they become a full royalty company (by dealing the U.S.) what do they do with all that extra cash? Does it get returned to us shareholders in the form of a special dividend? As you can see I am quite a novice with this but so much is unknown - at least to me.
And, are you saying that when they originally planned the BB that they had no idea that they would be going down this royalty road? Don't get me wrong the royalty road is quite good for anyone buying right in here now. But for some of us looking to recoup our long term losses I don't think this plan helps us in anything but a very long time.
Market Data 
Markets 
AI
